Vitrectomy and Bevacizumab for Diffuse Diabetic Macular Edema
Phase 3
Terminated
- Conditions
- Diffuse Diabetic Macular Edema
- Registration Number
- NCT00571142
- Lead Sponsor
- Asociación para Evitar la Ceguera en México
- Brief Summary
To Evaluate combined effect of vitrectomy and bevacizumab to stabilize retinal thickness and visual acuity in patients with diffuse diabetic macular edema and their relation to renal disease.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
- Older than 25 yo
- Diffuse diabetic macular edema with or without previous treatment
Exclusion Criteria
- Another retinal disease
- Pregnancy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Retinal thickness 3 months
- Secondary Outcome Measures
Name Time Method Visual acuity 3 months
Trial Locations
- Locations (1)
Asociacion para Evitar la Ceguera en Mexico I.A.P.
🇲🇽Mexico, Mexico
Asociacion para Evitar la Ceguera en Mexico I.A.P.🇲🇽Mexico, Mexico